FORLANI, GRETA
 Distribuzione geografica
Continente #
NA - Nord America 10.169
EU - Europa 6.092
AS - Asia 4.083
SA - Sud America 411
Continente sconosciuto - Info sul continente non disponibili 171
AF - Africa 73
OC - Oceania 19
Totale 21.018
Nazione #
US - Stati Uniti d'America 9.961
IT - Italia 3.033
SG - Singapore 1.273
CN - Cina 994
UA - Ucraina 882
VN - Vietnam 574
SE - Svezia 470
HK - Hong Kong 463
TR - Turchia 448
DE - Germania 375
BR - Brasile 334
FI - Finlandia 289
IE - Irlanda 255
GB - Regno Unito 207
FR - Francia 198
RU - Federazione Russa 155
CA - Canada 110
IN - India 76
BD - Bangladesh 72
JP - Giappone 55
MX - Messico 47
PL - Polonia 43
BE - Belgio 37
AR - Argentina 33
NL - Olanda 30
ES - Italia 25
IQ - Iraq 22
AT - Austria 17
CZ - Repubblica Ceca 17
ZA - Sudafrica 17
AU - Australia 16
LT - Lituania 15
NG - Nigeria 15
CR - Costa Rica 12
EC - Ecuador 12
MA - Marocco 12
SA - Arabia Saudita 12
ID - Indonesia 10
PK - Pakistan 10
VE - Venezuela 10
CH - Svizzera 9
CO - Colombia 9
EG - Egitto 8
PH - Filippine 8
IR - Iran 7
NI - Nicaragua 7
SV - El Salvador 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
IL - Israele 6
KR - Corea 6
UZ - Uzbekistan 6
AL - Albania 5
JO - Giordania 5
PR - Porto Rico 5
DO - Repubblica Dominicana 4
LU - Lussemburgo 4
MY - Malesia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
CL - Cile 3
CW - ???statistics.table.value.countryCode.CW??? 3
ET - Etiopia 3
GA - Gabon 3
HR - Croazia 3
KE - Kenya 3
MD - Moldavia 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
SC - Seychelles 3
TW - Taiwan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
BO - Bolivia 1
BT - Bhutan 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
KZ - Kazakistan 1
Totale 20.838
Città #
Milan 1.986
San Jose 874
Ashburn 832
Fairfield 779
Singapore 702
Jacksonville 693
Chandler 536
Woodbridge 533
Hong Kong 459
Houston 409
Dearborn 406
Council Bluffs 393
Ann Arbor 345
Seattle 315
Wilmington 300
Beijing 291
Dublin 252
Princeton 250
Cambridge 247
Dallas 212
Izmir 205
Nyköping 193
Boardman 160
New York 152
The Dalles 145
Rome 144
Dong Ket 143
Como 124
Los Angeles 122
Lauterbourg 118
Ho Chi Minh City 111
Chicago 93
Munich 83
Santa Clara 81
Helsinki 74
San Diego 61
Orem 58
São Paulo 53
Hanoi 52
Ogden 52
Tokyo 49
London 47
San Mateo 47
Guangzhou 46
Toronto 37
Brussels 36
Kocaeli 32
Warsaw 31
Hefei 30
Mexico City 30
Denver 27
Phoenix 27
Turku 27
Nanjing 26
Verona 26
Washington 26
Buffalo 25
Naples 25
San Francisco 25
Brooklyn 24
Kunming 23
Frankfurt am Main 22
Atlanta 21
Jinan 21
Montreal 19
Norwalk 19
Philadelphia 19
Manchester 18
Chennai 17
Gallarate 17
Shenzhen 17
Berlin 16
Shanghai 16
Varese 16
Abuja 15
Düsseldorf 15
Stockholm 15
Johannesburg 14
Nuremberg 14
Haiphong 13
Hangzhou 13
Mumbai 13
Boston 12
Brno 12
Edinburgh 12
Palermo 12
Amsterdam 11
Columbus 11
Pune 11
Vienna 11
Ankara 10
Falls Church 10
Kilburn 10
Magnago 10
Memphis 10
Poplar 10
San José 10
Shenyang 10
Changsha 9
Fuzhou 9
Totale 14.244
Nome #
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells 283
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state 263
CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches 245
Investigating Human T Cell Lymphotropic Retrovirus (HTLV) tax function with molecular and immunophenotypic techniques 244
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) 244
HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients 241
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1 225
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators 218
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL 218
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation 212
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells 212
Autoimmunità e Malattie Autoimmuni 207
CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: Toward the construction of an optimal anti-tumor vaccine 205
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1 202
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL 201
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication 200
Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation 196
Biophysics and molecular physiology of membrane transport systems 192
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells 191
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment 190
Modulation of the inward rectifier potassium channel IRK1 by the Ras signaling pathway 186
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells 185
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation. 184
Probiotic Bifidobacterium lactis, anti-oxidant vitamin E/C and anti-inflammatory dha attenuate lung inflammation due to pm2.5 exposure in mice 184
Tripartite motif 22 and class II transactivator restriction factors: Unveiling their concerted action against retroviruses 184
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation 183
The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis 182
Htlv-1 infection and pathogenesis: New insights from cellular and animal models 182
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma 178
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1. 177
-K448E mutation in the extracellular loop 5 rGAT1 gaba transporter induces alterations in interactions of substrates 177
New approaches of cancer vaccination and cancer immunotherapy based on the optimal stimulation of tumor-specific, MHC class II-restricted CD4+ T helper cells 175
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 171
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. 171
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction 170
Tax-1-mediated HTLV-1 replication and NF-kB activation is inhibited by the MHC-II transactivator CIITA 170
CIITA dependent MHC class II IA expression in tumor cells triggers CD4 T cell protective and long lasting antitumor immunity 170
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction 168
Temperature effects on the presteady-state and transport-associated currents of GABA cotransporter rGAT1 168
An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine 168
Role of anion-cation interactions on the pre-steady-state currents of the rat Na(+)-Cl(-)-dependent GABA cotransporter rGAT1 167
Altered sodium binding induced by K448E mutation in the extracellular loop 5 of GAT1 GABA transporter 167
Three kinds of currents in the canine betaine-GABA transporter BGT-1 expressed in Xenopus laevis oocytes 166
Distinct subcellular localization of HTLV-1 HBZ oncoprotein in the ATL leukemic and HAM/TSP patients. 166
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization 164
Tax-1-mediated NF-kB activation is inhibited by the MHC-II transactivator CIITA 164
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes 164
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells 163
HTLV-1 HBZ viral protein: A key player in HTLV-1 mediated diseases 162
Electrophysiological properties of the canine betaine/GABA transporter BGT-1 expressed in Xenopus laevis oocytes. 161
Electrophysiological properties of the canine betaine/GABA transporter BGT-1 expressed in Xenopus laevis oocytes. 161
Na+ AND Cl- EFFECTS ON THE NEURONAL GABA COTRANSPORTER rGAT1 160
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication. 160
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines 160
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients 160
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1 159
DNA ricombinante 158
CIITA-transfected tumor cells as potent, widely applicable anti-tumor vaccine due to their optimal triggering of long-lasting tumor-specific CD4+ T helper cells 157
Nociceptor-specific gene deletion reveals a major role for Na(v)1.7 (PN1) in acute and inflammatory pain 157
The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein 157
CIITA-transduced glioblastoma cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens 155
Na+ AND Cl- INTERACTIONS AT THE NEURONAL GABA COTRANSPORTER rGAT1 154
Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization 153
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication 152
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1 151
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication 150
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein 150
The constitutive activation of NF-kB by HTLV-1 Tax-1 oncoprotein is inhibited by the MHC class II transactivator CIITA 148
pH sensitivity conferred to rGAT1 gaba transporter by mutations in the extracellular loop 5. 147
Identification and characterization of proteins that, interacting with MeCP2, could be involved in Rett Syndrome 147
K448E mutation in the extracellular loop 5 of rgat1 gaba transporter induces alterations in interactions of substrates 146
The MHC Class II transactivator, CIITA,is a viral restriction factor for human oncogenic retroviruses 145
Association of the neuron specific Ras-exchange factor Ras-GRF1 with the microtubules cytoskeleton 145
Mutation K448E in the external loop 5 of rat GABA transporter rGAT1 induces pH sensitivity and alters substrates interactions 144
Modulation of extracellular signal-regulated kinases cascade by cronic Delta(99-tetrahydrocannabinol treatment 143
The guanine nucleotide exchange factor RasGRF1 directly binds microtubules via DHPH2-mediated interaction 143
Unveiling the hidden treasury: Ciita-driven mhc class ii expression in tumor cells to dig up the relevant repertoire of tumor antigens for optimal stimulation of tumor specific cd4+ t helper cells 143
Nociceptor-specific gene deletion using heterozygous Na(v)1.8-Cre recombinase mice 143
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine 141
Functional Characterization of CDKL5, a Novel Gene Involved in The Onset of Rett Syndrome and Infantile Spasms. 140
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway 140
Host-retrovirus interaction: role of CIITA in the inhibition of HTLV-1 replication and oncogenic potential 140
Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma 140
The guanine nucleotide exchange factor Ras-GRF1 directly binds microtubules via DH-PH2 mediated interaction 138
Mutations in specific aminoacid residues confer ph sensitivity to the rat gaba cotrasporter Gat1 137
Modulation of the inward rectifier potassium channel IRK1 by the Ras signalling pathway 134
The MHC class II transactivator CIITA acts as a restriction factor for HIV in human myeloid cells. 134
A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells 133
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway 133
Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T cell leukemia 133
Modulation of the inward rectifier potassium channel IRK1 by the Ras pathway 131
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma 130
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1 127
Modulation of the inward rectifier potassium channel IRK1 by the Ras signalling pathway 127
The modulation of the inward rectifier potassium channel IRK1 by the Ras pathway 125
Functional characterization of CDKL5, a novel gene involved in Rett syndrome and infantile spams associated with mental retardation 125
An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma 124
The MHC-II Transactivator CIITA, a Viral Restriction Factor Targeting Human T-Cell Lymphotropic Virus Type 1 Tax-1 Function and Inhibiting Viral Replication. 124
Functional Characterization of CDKL5, a novel gene involved in the onset of Rett syndrome 122
Functional characterization of CDKL5, a novel gene involved in the onset of Rett Syndrome 122
Totale 16.714
Categoria #
all - tutte 83.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022825 0 0 0 94 53 50 37 61 64 178 130 158
2022/20231.667 158 36 74 177 137 388 1 225 247 91 80 53
2023/20243.127 500 488 523 563 557 268 14 37 87 21 13 56
2024/20252.032 20 18 343 104 98 119 72 132 242 123 177 584
2025/20265.085 393 321 194 706 454 335 1.097 319 558 345 242 121
2026/20271.410 110 232 679 389 0 0 0 0 0 0 0 0
Totale 21.018